Abstract
Tumors containing elements of both papillary thyroid carcinoma (PTC) and squamous cell carcinoma (SCC) are rare but well documented. When they present initially as metastatic disease in an organ that can harbor a primary SCC, the possibility of a tumor to tumor metastasis (TTM) must be considered. The aim of this case study is to illustrate how BRAF mutational analysis can be used to help differentiate between these two diagnoses. We report a 63-year-old male with a longstanding history of PTC metastatic to the brain and lymph nodes who presented to our institution with a right lower lobe lung mass after a 2-year recurrence-free interval. Histopathologic and immunohistochemical analysis revealed a composite neoplasm with distinct elements of both PTC and SCC. We performed BRAF V600E (c.1799 T > A) mutational analysis to help elucidate the origin of each component. This is the first time that BRAF sequencing has been used to discriminate between dedifferentiated PTC and TTM, to the best of our knowledge. In the context of metastatic PTC with SCC dedifferentiation, the presence of the identical BRAF V600E (c.1799 T > A) mutation in both components might help rule out tumor to tumor metastasis.
References
LiVolsi VA, Merino MJ (1978) Squamous cells in the human thyroid gland. Am J Surg Pathol 2:133–140
Kleer CG, Giordano TJ, Merino MJ (2000) Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Mod Pathol 13:742–746
Ito Y, Hirokawa M, Higashiyama T et al (2012) Biological behavior of papillary carcinoma of the thyroid including squamous cell carcinoma components and prognosis of patients who underwent locally curative surgery. J Thyroid Res 2012:230283. doi:10.1155/2012/230283
Ryan N, Walkden G, Lazic D, Tierney P (2015) Collision tumors of the thyroid: a case report and review of the literature. Head Neck. doi:10.1002/hed.23936
Katsuya Y, Yoshida A, Watanabe S, Tsuta K (2015) Tumour-to-tumour metastasis from papillary thyroid carcinoma with BRAF mutation to lung adenocarcinoma with EGFR mutation: the utility of mutation-specific antibodies. Histopathology 67:262–266
Matsukuma S, Kono T, Takeo H, Hamakawa Y, Sato K (2013) Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study. Virchows Arch 463:525–534
Hashimoto K, Yamamoto H, Nakano T et al (2011) Tumor-to-tumor metastasis: lung adenocarcinoma metastasizing to a follicular variant of papillary thyroid carcinoma. Pathol Int 61:435–441
Xue L, Luan Z, Liu Y et al (2013) Pulmonary metastasis of a papillary thyroid carcinoma and primary lung adenocarcinoma: two coincident carcinomas at the same location. Diagn Pathol 8:26
Nonomura A, Mizukami Y, Shimizu J, Watanabe Y, Kamimura R, Takashima T (1994) Two patients with metastasis of cancer to other neoplasm: a thyroid carcinoma metastatic to a lung carcinoma and a gastric carcinoma metastatic to a thyroid adenoma. Endocr Pathol 5:233–239
Brustugun OT, Khattak AM, Trømborg AK et al (2014) BRAF-mutations in non-small cell lung cancer. Lung Cancer 84:36–38
Kenmotsu H, Serizawa M, Koh Y et al (2014) Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays. BMC Cancer 14:786
Lim YC, Kim WS, Choi EC (2008) Collision metastasis of squamous carcinoma of the oral tongue and incidental thyroid papillary carcinoma to a single cervical lymph node. Int J Oral Maxillofac Surg 37:494–496
Jacobson AS, Wenig BM, Urken ML (2008) Collision tumor of the thyroid and larynx: a patient with papillary thyroid carcinoma colliding with laryngeal squamous cell carcinoma. Thyroid 18:1325–1328
Gopal PP, Montone KT, Baloch Z, Tuluc M, LiVolsi V (2011) The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma. Thyroid 21:493–499
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The patient gave informed consent, and the study was performed according to the Declaration of Helsinki. No ethics committee approval was required, because this was a case report of a single patient.
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Acosta, A.M., Pins, M.R. Papillary thyroid carcinoma with extensive squamous dedifferentiation metastatic to the lung: BRAF mutational analysis as a useful tool to rule out tumor to tumor metastasis. Virchows Arch 468, 239–242 (2016). https://doi.org/10.1007/s00428-015-1875-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-015-1875-8